Wilson Sonsini Advises Solv on $45 Million Series C
- Client Highlights
- Life Sciences
- Digital Health
On May 26, 2022, Solv, which delivers everyday healthcare on demand, announced it had raised $45 million in equity in its Series C funding round, which included participation from a syndicate of 75 female investors, 60 percent of whom are women of color and 33 percent of whom are first-time investors. The funding round was led by Acrew Capital and Corner Ventures, with participation from existing investors Benchmark and Greylock. Wilson Sonsini Goodrich & Rosati advised Solv on the transaction.
Solv is on a mission to make affordable, high-quality, same-day, and next-day care easy to access for all. Today, 150 million Americans live within five miles of a same-day bookable appointment with a Solv provider and 1 in 16 Americans have used Solv to schedule care. Solv CEO and co-founder Heather Fernandez used fundraising efforts to build a diverse investor base representative of Solv's user base.
The Wilson Sonsini team that advised Solv on the transaction included Rezwan Pavri, Lang Liu, Alex Youssef, and Avery Minor.
For more information, please see Solv's press release.